FDA Warns Against ‘Microdosing’ Mushroom Chocolate Bars Linked to Severe Illnesses

Four states have reported cases of illness related to the consumption of Diamond Shruumz-brand Microdosing Chocolate Bars.

The Food and Drug Administration (FDA) has taken several actions in response to the reported illnesses from the Diamond Shruumz-brand Microdosing Chocolate Bars. These actions include:

1. Warning the public: The FDA has issued a warning to consumers against consuming the chocolate bars due to the potential risk of illness. This warning aims to protect consumers from further harm and to raise awareness about the potential dangers associated with consuming the product.

2. Investigating the cause of illnesses: The FDA, in collaboration with the Centers for Disease Control and Prevention (CDC), poison control centers, and state health agencies, is actively investigating the cause of the illnesses associated with the chocolate bars1. This investigation seeks to determine the source of the contamination and understand why the product has caused illnesses in some consumers.

3. Sampling and analysis: The FDA has initiated sample collection and analysis of the chocolate bars to identify any potential contaminants or harmful substances that may be responsible for the reported illnesses. This process involves testing the product for various pathogens, toxins, and other harmful substances that may cause adverse health effects.

4. Traceback: The FDA is conducting a traceback investigation to identify the source and distribution of the implicated chocolate bars. This process involves tracking the product through the supply chain, from the manufacturer to the retail level, to identify any patterns or commonalities that may help pinpoint the cause of the contamination.

5. Inspection: The FDA may initiate an official examination, or inspection, of the operational processes of the manufacturing facility to determine its compliance with federal regulations. This may include record collection and sample collection to assess the safety and quality of the products produced at the facility.

6. Updates and advisories: The FDA is responsible for providing updates and advisories to the public as new information becomes available during the investigation. This helps to keep the public informed about any developments in the case and ensures transparency in the FDA's response efforts.

In summary, the FDA has taken a multi-faceted approach to address the reported illnesses from the Diamond Shruumz-brand Microdosing Chocolate Bars. These actions are designed to protect public health, identify the cause of the illnesses, and ensure that appropriate measures are taken to prevent future incidents.